Bis-(sulfonylamino) derivatives in therapy 066

Details for Australian Patent Application No. 2008321577 (hide)

Owner AstraZeneca AB

Inventors Sohn, Daniel; Kers, Annika; Narhi, Katja; Viklund, Jenny; Ek, Maria; Holenz, Jorg; Von Berg, Stefan; Nordvall, Gunnar; Johansson, Martin H.; Ohberg, Liselotte; Bylund, Johan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008321577

PCT Pub. Number WO2009/064251

Priority 60/988,164 15.11.07 US

Filing date 14 November 2008

Wipo publication date 22 May 2009

Acceptance publication date 26 May 2011

International Classifications

C07C 311/51 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/145 (2006.01) - having sulfur atoms, e.g. thiurams (NC(S)SC(S)N or NC(S)SSC(S)N)

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/04 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/78 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 263/57 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/64 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 307/68 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 307/79 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/52 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064251 Priority application(s): WO2009/064251

26 May 2011 Application Accepted

  Published as AU-B-2008321577

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321599-Method of manufacturing crystalline silicon solar cells using co diffusion of boron and phosphorus

2008321575-A process for the preparation of (3aR,4S, 6R, 6aS)-6-amino-2, 2dimethyltetrahydro-3aH-cyclopenta[d] [1,3] dioxol-4-ol dibenzoyl-L-tartrate and to products of said process